ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Stryker Announces Commercial Launch of Q Guidance System With Cranial Guidance Software

Stryker’s navigation system offers surgeons a comprehensive planning and guidance solution for complex cranial procedures.

Stryker (NYSE: SYK), one of the world’s leading medical technology companies, has commercially launched its Q Guidance System with Cranial Guidance Software to provide surgeons with an image-based planning and intraoperative guidance system that assists in positioning instruments and identifying patient anatomy during cranial surgery. The software can be used for craniotomies, skull base and transsphenoidal procedures, shunt placements, and biopsies.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230711948261/en/

Stryker's Q Guidance System with Cranial Guidance Software includes a touchscreen monitor for control inside/outside the sterile field that provides high-performance 2D-3D visualization. (Photo: Business Wire)

Stryker's Q Guidance System with Cranial Guidance Software includes a touchscreen monitor for control inside/outside the sterile field that provides high-performance 2D-3D visualization. (Photo: Business Wire)

“With Cranial Guidance Software powered by Q, neurosurgeons have more surgical planning and guidance capabilities than ever before, with a special focus on biopsies and shunt placements,” said Robbie Robinson, president of Stryker’s Spine division. “This technology has the potential to become the standard of care and a possible means to increase accuracy and efficiency in the operating room.”

The Q Guidance System with Cranial Guidance Software uses both active and passive tracking technology to provide groundbreaking planning and guidance capabilities that include:

  • A proprietary camera: Stryker’s new 4th generation FP8000 camera offers increased speeds compared to products currently offered in the market.1
  • Dual PC system: One PC powers the operating system's applications while the other provides real-time patient data.
  • Diffusion Tensor Imaging (DTI) and tractography: DTI uses anisotropic diffusion to estimate the brain's axonal organization, reconstructed in 3D.
  • Precision Targeting System: Enables navigated biopsy of cranial tissue by using comprehensive guidance data and imaging to pre-plan an approach for entry point.
  • Electromagnetic catheter placement: Enables pinless shunt procedures.

“With Stryker’s new camera technology, we were able to quickly register patients using the CranialMask Tracker,” said Dr. J.D. Day, M.D. of UAMS Health in Little Rock, Arkansas. “The new user interface and workflows are slick, and our staff loves the intuitive new views like 3D targeting and the new skull stripping feature.”

The Q Guidance System with Cranial Guidance Software was used at six early product surveillance sites in May 2023.

Learn more about this new technology at strykeronegiantleap.com.

References:

1. Stryker data on file.

About Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually.

More information is available at www.stryker.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.